Advertisement
 
YOU ARE HERE: LAT HomeCollectionsClinical Trial
IN THE NEWS

Clinical Trial

HEALTH
December 13, 1999 | BOB ROSENBLATT
Armed with information gained from the Internet and elsewhere, more patients than ever are referring themselves to clinical trials and tests of experimental drugs. That's a change from a time when most patients relied on their doctors to get into research studies. They are joining trials of experimental cancer drugs, new therapies to relieve arthritis pain and new treatments for depression.
Advertisement
BUSINESS
May 11, 2010 | By Bruce Japsen
Reporting from Chicago After decades of research and multiple failed attempts to find a treatment, the pharmaceutical industry is entering a crucial phase in the search for a drug that can slow, or stop, the progression of Alzheimer's disease. Drug makers see huge moneymaking potential because of the aging population. Alzheimer's afflicts more than 5 million Americans and is one of the leading causes of death in the United States, according to the Centers for Disease Control and Prevention.
CALIFORNIA | LOCAL
August 22, 2006 | Christian Berthelsen, Times Staff Writer
The National Institutes of Health have reopened an inquiry into the activities of two UC Irvine psychiatrists in the wake of a report in The Times that they skirted the school's patient safety review board to test a drug without permission from the university. The NIH, the primary government agency for funding of medical research, previously had looked into the drug company test by Steven G. Potkin and William E. "Biff" Bunney in 2005 after it received an anonymous complaint.
HEALTH
January 1, 2001 | GARRET CONDON, HARTFORD COURANT
Drug companies have pills aplenty in the pipeline, but they won't make it to market until they've been tested on humans. Finding the right patients for trials of new drugs is a costly headache, though, for pharmaceutical firms and for the federal government, which also sponsors experimental trials. Meanwhile, for people who are seriously ill, the appropriate trial can mean a shot at a new treatment that might help. This could be a job for . . . the Internet.
HEALTH
November 21, 2005
Chromium is an essential trace mineral found in a variety of foods, including whole grains, cereals, spices (such as black pepper), broccoli, mushrooms, cheese, seafood and meat. In the body, it plays a role in metabolizing fats and carbohydrates and controlling blood levels of sugar. The body has a hard time absorbing chromium supplements in mineral form; it is absorbed more easily when it's bound to another molecule.
BUSINESS
July 16, 1995
Isis Pharmaceuticals was pleased to be included in the "Biotech Blues" (July 9) article depicting the challenges biotechnology faces in raising the necessary capital to fund research and development. We would like to correct some information that was referenced in the article concerning the timing of clinical trials for two of the company's compounds. The drug discovery and development process is a high-risk venture, and it is difficult to predict the timelines for when compounds will move from one phase of clinical testing to another, and for when each of those phases will be completed.
Los Angeles Times Articles
|